Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating revenue | 7.18%2.16B | -2.95%1.37B | -1.15%706.4M | 4.08%2.93B | 5.15%2.02B | 12.15%1.41B | 18.35%714.64M | 46.05%2.81B | 50.83%1.92B | 29.38%1.26B |
| Net interest income | 110.38%325.62M | 30.20%242.7M | -0.27%106.36M | -36.90%395.11M | -65.60%154.78M | -40.43%186.41M | -25.33%106.65M | 6.96%626.19M | 23.54%449.94M | 54.31%312.92M |
| -Interest income | 12.51%672.77M | -8.35%420.95M | 4.66%238.92M | -5.58%913.34M | -16.82%597.96M | -1.18%459.3M | -1.84%228.28M | 28.76%967.31M | 32.60%718.87M | 34.29%464.78M |
| -Less:Interest expense | -21.67%347.14M | -34.68%178.25M | 8.98%132.56M | 51.92%518.23M | 64.79%443.18M | 79.70%272.89M | 35.55%121.63M | 105.68%341.12M | 51.17%268.93M | 5.95%151.86M |
| Net commission income | -12.64%1.03B | -12.60%709.19M | -20.07%304.47M | 7.63%1.66B | 14.07%1.18B | 34.06%811.45M | 39.04%380.94M | 11.70%1.54B | 5.30%1.03B | -8.48%605.28M |
| -Commission income | -12.86%1.03B | -12.91%709.38M | -20.57%304.57M | 7.29%1.67B | 13.64%1.18B | 33.47%814.52M | 39.89%383.42M | 11.99%1.55B | 5.73%1.04B | -7.78%610.26M |
| -Less:Commission expense | -90.75%306.12K | -93.80%190.49K | -96.15%95.62K | -57.54%3.42M | -51.37%3.31M | -38.32%3.07M | 2,101.79%2.49M | 125.43%8.06M | 179.98%6.8M | 1,012.22%4.98M |
| Invest income | 4.92%686.25M | -31.16%308.77M | 8.07%229.39M | 28.55%894.78M | 28.75%654.05M | 61.33%448.53M | 49.48%212.26M | 244.62%696.04M | 450.27%508M | 221.70%278.03M |
| Asset deal income | -444.84%-7.05K | -333.97%-5.61K | ---5.52K | 182.64%259.12K | -101.33%-1.29K | ---1.29K | ---- | 154.84%91.68K | 423.29%97.07K | ---- |
| Other revenue | 16.53%1.58M | 16.53%1.58M | 16.53%1.58M | 52.49%1.35M | 52.49%1.35M | 52.49%1.35M | 52.49%1.35M | -85.19%887.19K | -85.19%887.19K | 2.08%887.19K |
| Operating payout | 7.18%838.43M | -19.22%398.08M | -15.36%189.25M | -20.15%1.09B | -4.58%782.3M | 8.05%492.77M | 41.47%223.59M | 69.26%1.37B | 81.74%819.88M | 30.97%456.06M |
| Operating and admin expense | 7.23%648.47M | 6.43%430.05M | 6.36%194.15M | 13.14%828.47M | 13.99%604.78M | 30.96%404.06M | 2.74%182.54M | 37.80%732.27M | 68.31%530.56M | 51.52%308.54M |
| Operating tax surcharges | 12.90%20.81M | -7.91%12.05M | -1.18%6.31M | 4.16%26.05M | 4.51%18.43M | 10.88%13.09M | 8.64%6.39M | 31.21%25.01M | 30.55%17.64M | 29.78%11.8M |
| Credit Impairment Loss | 6.34%168.65M | -158.93%-44.36M | -132.98%-11.38M | -61.16%236.75M | -41.52%158.59M | -44.39%75.29M | 234.44%34.5M | 138.55%609.56M | 122.49%271.19M | 0.17%135.38M |
| Other operating cost | 0.00%497.55K | 0.00%331.7K | 0.00%165.85K | 0.00%663.39K | 0.00%497.54K | 0.00%331.7K | 0.00%165.85K | 0.00%663.39K | 0.00%497.54K | 0.00%331.7K |
| Operating profit | 7.18%1.32B | 5.81%968.73M | 5.32%517.15M | 27.01%1.84B | 12.43%1.23B | 14.49%915.54M | 10.16%491.05M | 29.28%1.45B | 33.83%1.1B | 28.49%799.67M |
| Add:Nonoperating income | 11,142.24%112.52K | 10,971.59%110.79K | 1,230,423.88%8.24K | -65.70%3.33K | -89.69%1K | 24.58%1K | 45.65%0.67 | -90.04%9.7K | 12,129,837.50%9.7K | 1,003,975.00%803.26 |
| Less:Nonoperating expense | 68.41%1.73M | 25.02%1.2M | 26.83%1.17M | 14.66%9.99M | 96.33%1.03M | 353.75%956.69K | 353.07%918.94K | 148.33%8.71M | -64.06%522.67K | -84.64%210.84K |
| Total profit | 7.14%1.32B | 5.80%967.64M | 5.28%515.99M | 27.09%1.83B | 12.39%1.23B | 14.40%914.58M | 10.00%490.13M | 28.89%1.44B | 34.01%1.1B | 28.74%799.46M |
| Less:Income tax cost | 8.84%324.96M | 5.97%242.03M | 5.28%129.01M | 31.22%464.67M | 12.72%298.58M | 14.12%228.39M | 9.91%122.53M | 28.03%354.11M | 29.27%264.88M | 28.80%200.14M |
| Net profit | 6.60%996.05M | 5.74%725.61M | 5.27%386.98M | 25.73%1.36B | 12.28%934.38M | 14.49%686.19M | 10.03%367.6M | 29.18%1.08B | 35.59%832.18M | 28.72%599.32M |
| Net profit from continuing operation | 6.60%996.05M | 5.74%725.61M | 5.27%386.98M | 25.73%1.36B | 12.28%934.38M | 14.49%686.19M | 10.03%367.6M | 29.18%1.08B | 35.59%832.18M | 28.72%599.32M |
| Net profit of parent company owners | 6.60%996.05M | 5.74%725.61M | 5.27%386.98M | 25.73%1.36B | 12.28%934.38M | 14.49%686.19M | 10.03%367.6M | 29.18%1.08B | 35.59%832.18M | 28.72%599.32M |
| Earning per share | ||||||||||
| Basic earning per share | 6.62%0.1948 | 5.74%0.1419 | 5.29%0.0757 | 25.70%0.2661 | 12.29%0.1827 | 14.51%0.1342 | 10.11%0.0719 | 0.14%0.2117 | 5.10%0.1627 | -0.26%0.1172 |
| Diluted earning per share | 6.62%0.1948 | 5.74%0.1419 | 5.29%0.0757 | 25.70%0.2661 | 12.29%0.1827 | 14.51%0.1342 | 10.11%0.0719 | 0.14%0.2117 | 5.10%0.1627 | -0.26%0.1172 |
| Other composite income | 76.28%-57.79M | |||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---57.79M | ---- | ---- |
| Total composite income | 6.60%996.05M | 5.74%725.61M | 5.27%386.98M | 32.82%1.36B | 12.28%934.38M | 14.49%686.19M | 10.03%367.6M | 72.40%1.02B | 41.62%832.18M | 36.38%599.32M |
| Total composite income of parent company owners | 6.60%996.05M | 5.74%725.61M | 5.27%386.98M | 32.82%1.36B | 12.28%934.38M | 14.49%686.19M | 10.03%367.6M | 72.40%1.02B | 41.62%832.18M | 36.38%599.32M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Sigma Accounting Firm (Special General Partnership) | -- | -- | -- | Sigma Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.